MRFRの分析によると、血管スクリーニングの市場規模は2023年に1.76 (10億ドル) と推定されました。この市場は2024年の1.86 (10億ドル) から2035年までに3.5 (10億ドル) に成長し、予測期間 (2025-2035) のCAGRは約5.89%になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. VASCULAR SCREENING MARKET, BY TEST TYPE (USD BILLION)
6.1. Ultrasound
6.2. CT Angiography
6.3. MRI Angiography
6.4. X-ray Angiography
7. VASCULAR SCREENING MARKET, BY APPLICATION (USD BILLION)
7.1. Peripheral Artery Disease
7.2. Aneurysm Detection
7.3. Carotid Artery Disease
7.4. Venous Disease
8. VASCULAR SCREENING MARKET, BY END USE (USD BILLION)
8.1. Hospitals
8.2. Diagnostic Laboratories
8.3. Specialty Clinics
8.4. Home Healthcare
9. VASCULAR SCREENING MARKET, BY PRODUCT TYPE (USD BILLION)
9.1. Devices
9.2. Consumables
9.3. Software
9.4. Services
10. VASCULAR SCREENING MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Vascular Screening Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Vascular Screening Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Abbott Laboratories
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Philips Healthcare
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. GE Healthcare
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Terumo Corporation
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Fujifilm Holdings
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Becton Dickinson
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. NIPRO Corporation
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. SonoSite
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Getinge AB
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Hitachi Medical Systems
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Siemens Healthineers
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Boston Scientific
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Canon Medical Systems
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Medtronic
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Johnson and Johnson
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 8. US VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 9. US VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 10. US VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 11. US VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 28. UK VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 29. UK VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 30. UK VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 31. UK VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 58. APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 59. APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 60. APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 61. APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 128. MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 129. MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 130. MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 131. MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA VASCULAR SCREENING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA VASCULAR SCREENING MARKET ANALYSIS
FIGURE 3. US VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 4. US VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 5. US VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 6. US VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 7. US VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 9. CANADA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 10. CANADA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 11. CANADA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 12. CANADA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE VASCULAR SCREENING MARKET ANALYSIS
FIGURE 14. GERMANY VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 15. GERMANY VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 16. GERMANY VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 17. GERMANY VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 18. GERMANY VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 20. UK VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 21. UK VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 22. UK VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 23. UK VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 25. FRANCE VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 26. FRANCE VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 27. FRANCE VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 28. FRANCE VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 30. RUSSIA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 31. RUSSIA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 32. RUSSIA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 33. RUSSIA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 35. ITALY VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 36. ITALY VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 37. ITALY VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 38. ITALY VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 40. SPAIN VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 41. SPAIN VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 42. SPAIN VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 43. SPAIN VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 45. REST OF EUROPE VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 46. REST OF EUROPE VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 47. REST OF EUROPE VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 48. REST OF EUROPE VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC VASCULAR SCREENING MARKET ANALYSIS
FIGURE 50. CHINA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 51. CHINA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 52. CHINA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 53. CHINA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 54. CHINA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 56. INDIA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 57. INDIA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 58. INDIA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 59. INDIA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 61. JAPAN VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 62. JAPAN VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 63. JAPAN VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 64. JAPAN VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 66. SOUTH KOREA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 67. SOUTH KOREA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 68. SOUTH KOREA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 69. SOUTH KOREA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 71. MALAYSIA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 72. MALAYSIA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 73. MALAYSIA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 74. MALAYSIA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 76. THAILAND VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 77. THAILAND VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 78. THAILAND VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 79. THAILAND VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 81. INDONESIA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 82. INDONESIA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 83. INDONESIA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 84. INDONESIA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 86. REST OF APAC VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 87. REST OF APAC VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 88. REST OF APAC VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 89. REST OF APAC VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA VASCULAR SCREENING MARKET ANALYSIS
FIGURE 91. BRAZIL VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 92. BRAZIL VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 93. BRAZIL VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 94. BRAZIL VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 95. BRAZIL VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 97. MEXICO VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 98. MEXICO VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 99. MEXICO VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 100. MEXICO VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 102. ARGENTINA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 103. ARGENTINA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 104. ARGENTINA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 105. ARGENTINA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 107. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 108. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 109. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 110. REST OF SOUTH AMERICA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA VASCULAR SCREENING MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 113. GCC COUNTRIES VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 114. GCC COUNTRIES VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 115. GCC COUNTRIES VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 116. GCC COUNTRIES VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 118. SOUTH AFRICA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 119. SOUTH AFRICA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 120. SOUTH AFRICA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 121. SOUTH AFRICA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA VASCULAR SCREENING MARKET ANALYSIS BY TEST TYPE
FIGURE 123. REST OF MEA VASCULAR SCREENING MARKET ANALYSIS BY APPLICATION
FIGURE 124. REST OF MEA VASCULAR SCREENING MARKET ANALYSIS BY END USE
FIGURE 125. REST OF MEA VASCULAR SCREENING MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 126. REST OF MEA VASCULAR SCREENING MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF VASCULAR SCREENING MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF VASCULAR SCREENING MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: VASCULAR SCREENING MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: VASCULAR SCREENING MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: VASCULAR SCREENING MARKET
FIGURE 133. VASCULAR SCREENING MARKET, BY TEST TYPE, 2024 (% SHARE)
FIGURE 134. VASCULAR SCREENING MARKET, BY TEST TYPE, 2019 TO 2035 (USD Billions)
FIGURE 135. VASCULAR SCREENING MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 136. VASCULAR SCREENING MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
FIGURE 137. VASCULAR SCREENING MARKET, BY END USE, 2024 (% SHARE)
FIGURE 138. VASCULAR SCREENING MARKET, BY END USE, 2019 TO 2035 (USD Billions)
FIGURE 139. VASCULAR SCREENING MARKET, BY PRODUCT TYPE, 2024 (% SHARE)
FIGURE 140. VASCULAR SCREENING MARKET, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
FIGURE 141. VASCULAR SCREENING MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. VASCULAR SCREENING MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
